Command Palette

Search for a command to run...

mps-pharmaa

2.08+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

In the Pharmaceuticals & Drugs sector, MPS Pharmaa Ltd. shows significant underperformance compared to its peers, characterized by zero growth metrics and negative valuation ratios. However, companies like Sun Pharmaceutical and Cipla stand out with strong profitability and growth, while others like Divi's Laboratories show high valuations despite weak revenue growth. MPS Pharmaa Ltd. is positioned as a value pick due to its low market price but lacks profitability and growth metrics.

Key Points
  • MPS Pharmaa Ltd. exhibits no revenue growth and negative PE ratio, indicating severe financial distress.
  • Sun Pharmaceutical showcases the highest revenue growth (YoY: 8.42%) and strong profitability metrics (ROE: 16.13%).
  • Divi's Laboratories has the highest PE ratio (73.20) indicating overvaluation despite decent margins.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest revenue growth (YoY: 8.42%) and strong ROE (16.13%) with manageable debt.

Cipla Ltd.

Strong profitability (ROE: 16.63%) and good revenue growth (YoY: 13.28%) with low PEG ratio (0.35).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.